Evidence map›Paper›PMID 36502394›Full record

ReviewJournal of chemical theory and computation2023

CRYSTAL23: A Program for Computational Solid State Physics and Chemistry.

Alessandro Erba, Jacques K Desmarais, Silvia Casassa, Bartolomeo Civalleri, Lorenzo Donà, Ian J Bush, Barry Searle, Lorenzo Maschio, Loredana Edith-Daga, Alessandro Cossard and 5 more

Abstract readReview
In one paragraph

Review in Journal of chemical theory and computation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Crystal structure of seladelpar, CActa crystallographica. Section E, Crystallographic communications · 2026
    Article
  6. Article
  7. Article
  8. Crystal structure of clofarabine (form I), CActa crystallographica. Section E, Crystallographic communications · 2026
    Article
  9. Crystal structure of the (1Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  10. Article
  11. Crystal structure of binimetinib (Form A), CActa crystallographica. Section E, Crystallographic communications · 2026
    Article
  12. Avutometinib.Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  13. Levosimendan Form I, CActa crystallographica. Section E, Crystallographic communications · 2026
    Article
  14. Crystal structure of sunvozertinib, CActa crystallographica. Section E, Crystallographic communications · 2026
    Article
  15. Midodrine hydro-chloride Form A, CActa crystallographica. Section E, Crystallographic communications · 2026
    Article
  16. Article
  17. Adiabatic Connection Methods Applied to Molecular Crystals.Journal of chemical theory and computation · 2026
    Article
  18. Antifluorite-derived LiCatalysis science & technology · 2026
    Article
  19. Article
  20. Bepostastine besylate.IUCrData · 2026
    Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alessandro ErbaDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.ORCID 0000-0002-2986-4254
Jacques K DesmaraisDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.ORCID 0000-0001-9199-1898
Silvia CasassaDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.ORCID 0000-0003-0217-4920
Bartolomeo CivalleriDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.ORCID 0000-0003-3198-3161
Lorenzo DonàDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.ORCID 0000-0001-7735-3881
Ian J BushSTFC Rutherford Appleton Laboratory, Chilton Didcot, Oxfordshire OX11 0QX, United Kingdom.
Barry SearleSFTC Daresbury Laboratory, Daresbury, Cheshire WA4 4AD, United Kingdom.
Lorenzo MaschioDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.ORCID 0000-0002-4657-9439
Loredana Edith-DagaDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.
Alessandro CossardDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.
Chiara RibaldoneDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.ORCID 0000-0003-1866-5273
Eleonora AscrizziDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.
Naiara L MaranaDipartimento di Chimica, Università di Torino, via Giuria 5, 10125 Torino, Italy.ORCID 0000-0001-8979-1627
Jean-Pierre FlamentUniversité de Lille, CNRS, UMR 8523 ─ PhLAM ─ Physique des Lasers, Atomes et Molécules, 59000 Lille, France.
Bernard KirtmanDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Crystal program for quantum-mechanical simulations of materials has been bridging the realm of molecular quantum chemistry to the realm of solid state physics for many years, since its first public version released back in 1988. This peculiarity stems from the use of atom-centered basis functions within a linear combination of atomic orbitals (LCAO) approach and from the corresponding efficiency in the evaluation of the exact Fock exchange series. In particular, this has led to the implementation of a rich variety of hybrid density functional approximations since 1998. Nowadays, it is acknowledged by a broad community of solid state chemists and physicists that the inclusion of a fraction of Fock exchange in the exchange-correlation potential of the density functional theory is key to a better description of many properties of materials (electronic, magnetic, mechanical, spintronic, lattice-dynamical, etc.). Here, the main developments made to the program in the last five years (i.e., since the previous release, Crystal17) are presented and some of their most noteworthy applications reviewed.

Identifiers

PMID36502394
PMCPMC10601489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.